Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling and Up-regulation of Egr-1 in Hypoxic Macrophages

Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging

(2010) Shi Fang Yan et al.   BIOCHEMICAL PHARMACOLOGY

The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease

(2009) Shi Fang Yan et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model

(2008) Alexey Aleshin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Oxygen Deprivation Triggers Upregulation of Early Growth Response-1 by the Receptor for Advanced Glycation End Products

(2008) Jong Sun Chang et al.   CIRCULATION RESEARCH

RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium

(2008) L. G. Bucciarelli et al.   DIABETES

Macrophage roles following myocardial infarction

(2008) Jessica M. Lambert et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42

(2008) Barry I. Hudson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice

(2008) Evis Harja et al.   JOURNAL OF CLINICAL INVESTIGATION

RAGE Mediates Podocyte Injury in Adriamycin-induced Glomerulosclerosis

(2008) J. Guo et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY